AUSTIN BENNER: Open Payments
NPI 1124614953 · MIDDLEBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,436 in 76 payments from 14 companies in 2025. Trend: 2023 $1,733 · 2024 $1,543 · 2025 $1,436
Food & beverage: $1,436
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $378 |
| AstraZeneca Pharmaceuticals LP | 12 | $259 |
| ABBVIE INC. | 14 | $212 |
| Exact Sciences Corporation | 6 | $142 |
| GlaxoSmithKline, LLC. | 5 | $88 |
| Lilly USA, LLC | 4 | $76 |
| Dexcom, Inc. | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $45 |
| Ardelyx, Inc. | 1 | $33 |
Products named: Ozempic, FARXIGA, Cologuard Collection Kit, VRAYLAR, AIRSUPRA, QULIPTA, TRELEGY ELLIPTA, Dexcom G6 Transmitter.
Industry payments across PA — which companies pay providers there.
